| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 2e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.32 | 4e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.32 | 7e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.35 | 7e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |